U.S. Life Sciences Stock News

Brookdale Senior Living Inc. reported fourth-quarter 2025 revenue of US$754.09 million and a net loss of US$39.96 million, while full-year 2025 revenue reached US$3.19 billion with a net loss of US$262.69 million, alongside continued participation in major investor conferences. An interesting angle is that, despite higher annual revenue and a reduced quarterly loss, Brookdale’s full-year net loss and ongoing debt concerns coincided with AYAL Capital Advisors fully exiting its US$6.45 million...

Kinetik Holdings Inc. recently reported fourth-quarter 2025 revenue of US$430.42 million and net income of US$416.70 million, with full-year 2025 revenue of US$1.76 billion and net income of US$525.93 million, marking a sharp jump in earnings per share from continuing operations versus 2024. Alongside these results, Kinetik highlighted progress on projects such as the Kings Landing sour-gas conversion and the Barilla Draw acquisition, while outlining a 2026 “rebuilding” mandate focused on...

BlackSky Technology (BKSY) is back in focus after securing more than US$240 million in primarily international Gen 3 satellite contracts, expanding its imaging capacity and pairing that with narrower losses and higher gross margins. See our latest analysis for BlackSky Technology. The recent contract wins and Gen 3 launches come against a mixed price backdrop, with a 14.59% 1 month share price decline and 9.46% year to date share price loss. However, a 46.01% 1 year total shareholder return...

Enovis (ENOV) is back in focus after its latest earnings report paired a large non cash goodwill impairment with adjusted earnings per share above analyst estimates and a profit outlook that topped market expectations. See our latest analysis for Enovis. The strong 7 day share price return of 13.6% and 30 day share price return of 15.56% following Enovis' earnings and guidance update sits against a weaker backdrop. The 90 day share price return is 13.31% and the 1 year total shareholder...

In recent weeks, American Assets Trust's Executive Chairman Ernest S. Rady bought over US$212,000 of company stock across two transactions, lifting his indirect holdings to more than 8.1 million shares, shortly after the REIT posted mixed fourth-quarter 2025 results with earnings per share below forecasts but revenue ahead of expectations. These insider purchases come as commercial real estate sentiment weakens and interest rates remain elevated, suggesting leadership sees the portfolio’s...

Arch Capital Group recently declared quarterly dividends on its 13,200,000 Series F and 20,000,000 Series G non-cumulative preferred depositary shares, with payments scheduled for March 31, 2026 to holders of record as of March 15, 2026, subject to Bermuda law requirements and potential Board adjustments. This preferred dividend decision comes as Arch Capital’s latest filings highlight strong underwriting and investment outcomes, the integration of Allianz’s U.S. Middle Market P&C business,...

In recent months, Deluxe has drawn renewed attention as its Data Solutions business benefits from accelerating adoption of digital operations by financial institutions and small and medium-sized enterprises. This shift highlights the company’s growing exposure to higher-quality, recurring technology revenues while its traditional print products remain under pressure from digital alternatives. We’ll now examine how the strong momentum in Deluxe’s Data Solutions segment may reshape the...

In February 2026, Navios Maritime Partners L.P. reported fourth-quarter 2025 results showing higher sales of US$365.55 million and net income of US$117.33 million year over year, alongside a 20% increase in its quarterly distribution to US$0.06 per unit and completion of a buyback covering 5.45% of its units. While full-year 2025 net income of US$285.33 million and earnings per unit eased compared with the prior year, the combination of stronger quarterly performance, higher distributions,...

Why Denali Therapeutics Stock Is Back in Focus Denali Therapeutics (DNLI) is drawing fresh attention after reporting a wider net loss for the fourth quarter and full year, along with a new common stock shelf registration that signals possible future share issuance. See our latest analysis for Denali Therapeutics. At a share price of US$21.18, Denali’s short term momentum has been mixed, with a 4.9% 7 day share price return alongside a 16.63% 90 day share price return and a 30.18% year to date...

Centerspace (CSR) drew fresh attention after releasing fourth quarter and full year 2025 results, issuing 2026 earnings guidance that points to a net loss, and reaffirming its quarterly dividend payout. See our latest analysis for Centerspace. The latest earnings update and guidance arrived after a stretch where the 1 year total shareholder return was roughly flat at 0.05%, even as the share price return year to date declined 6.08%. This hints that momentum has softened despite dividends...

In February 2026, Portland General Electric reported full-year 2025 revenue of US$3,576 million and net income of US$306 million, while also disclosing lower earnings per share than the prior year. On the same day, the company completed a roughly US$480 million follow-on common stock offering, signaling a major capital raise that meaningfully alters its equity base and funding mix. We’ll now examine how this substantial equity issuance may influence Portland General Electric’s investment...

Daqo New Energy (DQ) stock is back in focus after the company released Q4 2025 results alongside fresh 2026 production guidance, combining its first positive EBITDA in six quarters with continued net losses. See our latest analysis for Daqo New Energy. At a share price of US$24.12, Daqo New Energy has a 1 year total shareholder return of 19.11%. However, the 3 year and 5 year total shareholder returns of 53.63% and 69.84% declines show that longer term momentum has been weak, despite the...

Innoviva, Inc. recently reported fourth-quarter 2025 revenue of US$114.61 million and net income of US$164.15 million, capping a full year in which revenue reached US$411.33 million and net income climbed to US$271.17 million. These results highlight the growing weight of the Innoviva Specialty Therapeutics platform in the business, alongside the U.S. FDA approval of NUZOLVENCE®, which together reinforce the company’s shift from a royalty-focused model toward a broader commercial portfolio...

In February 2026, BioLife Solutions, Inc. reported fourth-quarter 2025 sales of US$24.76 million, full-year 2025 sales of US$96.21 million, a reduced full-year net loss of US$4.60 million, and issued 2026 revenue guidance of US$112.5 million to US$115.0 million alongside an expectation of GAAP net income for the year. Management highlighted that growth was primarily driven by its biopreservation media franchise, now embedded in multiple approved cell and gene therapies, supported by a...

Enact Holdings (ACT) has drawn fresh attention after authorizing a US$350 million share repurchase program and securing a new US$435 million revolving credit facility, alongside an analyst upgrade to Strong Buy. See our latest analysis for Enact Holdings. The recent buyback authorization, new revolving credit facility and earnings upgrade come after a steady 30 day share price return of 5.20% and a 1 year total shareholder return of 24.39%, while the 3 year total shareholder return of 87.86%...

In February 2026, Bell Cyber and Radware expanded their partnership to launch an AI-driven, cloud-delivered security service that combines Radware’s application and API protection with Bell Cyber’s fully managed security operations for organizations across Canada and the U.S. A key feature of the new offering is its Canadian-managed operations model, which aims to meet data sovereignty and compliance needs while giving customers a single, consolidated platform for web, API, bot, and DDoS...

Arcos Dorados Holdings (NYSE:ARCO) has closed a long standing shelf registration covering 5,238,235 Class A shares linked to an employee stock ownership plan, an event that puts its capital structure moves back in focus. See our latest analysis for Arcos Dorados Holdings. The shelf registration closure comes after a period of solid trading momentum, with Arcos Dorados showing a 30-day share price return of 7.58%, a year-to-date share price return of 20.71%, and a 1-year total shareholder...

DRDGOLD (DRD) is back in focus after reporting half year earnings to December 31, 2025, with sales of ZAR 5,053.2 million and net income of ZAR 1,927.7 million. See our latest analysis for DRDGOLD. Those half year results land after a very strong run, with a 30 day share price return of 22.25% and a 90 day share price return of 29.62% pointing to building momentum. Meanwhile, the 1 year total shareholder return of 259.34% and 3 year total shareholder return of about 4.7x highlight how...

In February 2026, Seadrill Limited reported its fourth-quarter and full-year 2025 results, showing higher revenue of US$362 million for the quarter and US$1.44 billion for the year, but a net loss of US$10 million for the quarter and US$77 million for the year, including a US$22 million impairment on long-lived assets. Despite the headline loss, Seadrill highlighted record safety performance, strong EBITDA of US$353 million, new and extended contracts, and issued 2026 revenue guidance of...

Anywhere Real Estate Inc. has released its full-year 2025 results, reporting revenue of US$5,960 million compared with US$5,692 million in 2024, and a net loss of US$90 million versus US$128 million previously. The combination of higher revenue and a smaller net loss points to operational progress that investors may see as a sign of improving financial health, even though the business remains loss-making. We’ll now examine how this revenue growth and reduced net loss might reshape Anywhere...

Science Applications International Corp. has recently secured a US$95 million contract from the U.S. Government Accountability Office to modernize its Technical Information Services program with end-to-end IT solutions and a more secure, data-driven infrastructure. By embedding security, automation, and agile delivery into GAO’s technology stack, SAIC is positioning itself as a key partner in federal IT modernization and complex digital engineering projects. Next, we’ll examine how this GAO...

In recent days, Citigroup has been very active in capital markets, filing an omnibus shelf registration and issuing a wide range of senior and subordinated fixed‑rate and zero‑coupon notes across maturities from 2028 to 2056, while also closing the sale of its Russian operations, which added about US$4.00 billion to its Common Equity Tier 1 capital. At the same time, Citigroup is pushing further into digital finance by planning to integrate Bitcoin into its core banking systems by 2026,...

Recent enthusiasm around Synaptics (SYNA) has centered on stronger reported revenue, higher guidance, and its push into Edge AI and wireless, supported by the earlier purchase of Broadcom’s Wi Fi assets. See our latest analysis for Synaptics. At a share price of US$81.46, Synaptics has seen a 14.88% 90 day share price return and a 29.49% 1 year total shareholder return. This suggests momentum is building as investors react to stronger revenue, higher guidance, insider selling activity, and...

Cboe Global Markets (CBOE) is on investors’ radar after reporting record Q4 and full year 2025 results, with strong derivatives revenue and options momentum helping push the stock to an all time high. See our latest analysis for Cboe Global Markets. The earnings release has capped an eight day winning streak for Cboe Global Markets. The 30 day share price return of 13.08% and year to date share price return of 20.80% point to strong upside momentum, while the 1 year total shareholder return...